Pharmacokinetics of nicorandil in patien
β
M. Molinaro; G. Villa; M. B. Regazzi; A. Salvadeo; S. Segagni; R. Rondanelli; E.
π
Article
π
1992
π
Springer
π
English
β 489 KB
The pharmacokinetics of oral nicorandil 20 mg 12 hourly for 9 doses was evaluated in 21 hospitalized patients with angina pectoris due to coronary heart disease and with normal and impaired renal function. Patients were divided into 3 groups based on creatinine clearance (CLCr): GROUP I (n = 6) grea